The National Center for Clinical Laboratories (NCCL) released the 2018 National Clinical Laboratory EQA Report and Genecast Biotechnology passed with a full score the 2018 National EQA on HTS for Detection of Somatic Mutation in Cancer. 

160 laboratories from 19 provinces (municipalities and autonomous regions) participated in this proficiency test.  138 reported back, from which 121 qualified 87.7% (121/138) and 55.1% (76/138) attained full score. Genecast Biotechnology was in this full score group. This confirms Genecast Biotechnology leadership and first-class detection standard in the field of gene detection of tumors.